Glaxo Operations UK Limited, trading as Glaxo Wellcome Operations (manufacturing of unpackaged product, quality control of finished product)

The drug is intended for adults and children aged 12 years and older (weighing at least 35 kg) who belong to a risk group, for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact.

Dosage form: tablets, film-coated

ATC: J05AJ04